Macrogen Inc. | Mutual Funds
Mutual Funds that own Macrogen Inc.
DFA Emerging Markets Small Cap Series
76,933
0.73%
0
0.04%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
59,215
0.56%
18,451
0.01%
04/30/2018
Government Pension Fund - Global (The)
30,244
0.28%
0
0%
12/31/2017
Mirae Asset TIGER Health Care ETF
18,417
0.17%
5,833
0.43%
04/30/2018
Eaton Vance Parametric Tax Managed Emerging Markets Fund
13,950
0.13%
0
0.02%
06/30/2018
SPDR S&P International Small Cap ETF
4,527
0.04%
0
0.02%
09/06/2018
DFA Emerging Markets Social Core Equity Portfolio
3,090
0.03%
480
0.01%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
2,466
0.02%
0
0.01%
12/31/2017
John Hancock II - Emerging Markets Fund
1,760
0.02%
0
0.01%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
1,290
0.01%
0
0%
04/30/2018
| Address |
10/F, World Meridian Venture Center
Seoul SL 08511
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.macrogen.co.kr |
| Updated |
09/14/2018 |
| Macrogen, Inc. engages in the provision genetic research and biotechnology services. It services include genome sequencing, oligonucleotide, microarray, genetically engineered mouse, and clinical sequencing. The company was founded on June 5, 1997 and is headquartered in Seoul, South Korea. |
